Tasmar 100 mg
Tasmar 100 mg is a medicine authorised by Swissmedic under authorisation number 54055. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 February 1997 and the authorisation is valid without a time limit. ATC code N04BX01 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 54055 |
|---|---|
| Name | Tasmar 100 mg |
| Full name | Tasmar 100 mg, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | N04BX01 |
| First authorisation | 25 February 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tasmar 100 mg, Filmtabletten | A | 25 February 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N04BX01 | 01.08.0. | A |
| 13 | 30 | Tablette(n) | N04BX01 | 01.08.0. | A |
| 21 | 100 | Tablette(n) | N04BX01 | 01.08.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tasmar 100 mg authorised in Switzerland?
Yes. Tasmar 100 mg is authorised by Swissmedic under authorisation number 54055, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tasmar 100 mg have?
Tasmar 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tasmar 100 mg?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.